political economy of medical marijuana by anthony white

27
The Political Economy of Medical Marijuana: Are its costs overstated? Institute for Economic Inquiry Anthony White

Upload: anthony-white

Post on 15-Apr-2017

439 views

Category:

Documents


0 download

TRANSCRIPT

The Political Economy of Medical Marijuana: Are its costs overstated?

Institute for Economic Inquiry

Anthony White

White 1

1. Introduction

States are legalizing medical marijuana due to the potential benefits it might have

for people suffering with diseases. Despite the overwhelming evidence that has caused

40 out of 50 states to change their medical marijuana laws, Nebraska is still conflicted.

However, the time to act is now. Two bills have been introduced that would revise the

state’s laws on medical marijuana. The first bill (LB390, 20151), proposed by Senator

Crawford, allows very limited access to low THC-CBD oil for a group of patients

suffering from Intractable Epilepsy under the supervision of the Nebraska Medical

Center. This bill was passed May of 2015. The second bill (LB 643, 20152), proposed

by Senator Garrett, models itself on more comprehensive legalization that would allow

patients suffering from certain conditions access to marijuana for medicinal purposes.

Since 1996, twenty-three states as well as the District of Columbia have legalized

Marijuana for medicinal purposes for patients suffering from a number of conditions.

Proponents of this change argue that the drug offers various potential medical, societal

and economic benefits. They have faced criticism over the scientific merits of these

claims from opponents of the measure. Opponents have alleged costs that are associated

with weakening drug enforcement laws and the social and economic ills associated with

legalizing medical marijuana.

This paper seeks to find answers to the many questions surrounding the medical

marijuana legalization discussion. We will look at the number of Nebraska residents

affected by conditions treatable with medical marijuana and will analyze various clinical

trials and studies in medical marijuana states (MMS) to help identify possible outcomes

of medical marijuana if it were legalized in Nebraska.

In addition, we will look at the possible effects medical marijuana as a policy change

has on society as a whole. We will use data from various MMS to determine specific

1 LB 390, 2015, Legislature of Nebraska http://nebraskalegislature.gov/FloorDocs/104/PDF/Intro/LB390.pdf

2 LB 643, 2015, Legislature of Nebraska http://nebraskalegislature.gov/FloorDocs/104/PDF/Intro/LB643.pdf

White 2

patterns associated with the legalization of medical marijuana and what the implications

of these patterns are. This analysis examines the impact medical marijuana legalization

has on social ills such as crime, adolescent use, depression and suicide rates.

We will then look at the potential effects medical marijuana has on the economy. We

investigate monetary benefits and costs associated with medical marijuana. This includes

the potential for job creation and the possibility of cost savings for Nebraska police

departments. We examine the implications of this policy change on banks and the

liability they face while engaged in activities in violation of federal law as well as how

the inconsistency between state and federal law affects medical marijuana dispensaries.

The objective of this multi-perspective analysis is to serve as a summary of reliable

information for those interested in this controversial topic. Although this analysis will

not be able to discuss all aspects of the research, we hope to help you contemplate the

various benefits Nebraska would achieve if medical cannabis were legalized.

2. Historical Legality of Marijuana

Many treat the legalization of marijuana as a modern day experiment, however,

by looking at the historical context behind the criminalization of marijuana, one may

understand quite a different story. The idea that marijuana has been historically illegal is

a misconception about the drug and in fact, the illegality of the drug is a historical

anomaly. The current logic used to determine the illegality of the drug comes from a

period of anti-immigrant fear mongering beginning in the late 1920’s. Thus, instead of

considering the legalization of the drug to be an experiment, it may be more accurate to

understand the criminalization of marijuana as a failed experiment to rid society of

artificially created social ills associated with immigrants. Although, marijuana had been

an illegal product during the majority of the 20th century in the United States, the fact is

marijuana has played a major role throughout the history of the country. Therefore, it is

necessary to understand the historical context around the legality of the marijuana in

order to understand the implication of its current status in the United States.

2.1 Marijuana as a Legal Commodity

White 3

Marijuana has not always been illegal in the United States. In fact, marijuana and

hemp (the plant from which marijuana is derived) have been a part of American History

since the 1600’s when it was used to make ropes, sails and clothing. In the late ninetieth

century, marijuana became popular in medicine and was sold openly in pharmacies.

2.2 Marijuana and Anti-Immigrant Fear-Mongering

In the early 1900’s, Mexican immigrants introduced the recreational use of

marijuana. Prejudice took over and as a result, the American public began associating

marijuana with these Mexican immigrants. As the Great Depression hit and

unemployment skyrocketed, the American people felt resentment toward the immigrants

and their relation to marijuana. In effect, the public’s fear of marijuana grew even more

and by 1931, it had been outlawed in 29 states.3

Anti-immigration and anti-marijuana propaganda became prevalent in the 1930’s.

Much of the further hysteria around the drug can be attributed to the founding of the

Federal Bureau of Narcotics (FBN) in 1930. Headed by Harry Anslinger, the

organization became known for its campaign against marijuana.4 During this campaign,

he often linked anti-immigrant sentiments and racial minorities with marijuana.

Anslinger is documented as saying:

Most marijuana smokers are Negroes, Hispanics, jazz musicians, and entertainers. Their

satanic music is driven by marijuana, and marijuana smoking by white women makes

them want to seek sexual relations with Negroes, entertainers, and others. It is a drug that

causes insanity, criminality, and death — the most violence-­‐causing drug in the history of

mankind.5

He later testified to congress in favor of the Marihuana Tax Act of 1937:

3 Marijuana Timeline http://www.pbs.org/wgbh/pages/frontline/shows/dope/etc/cron.html

4 Federal Bureau of Narcotics https://www.addiction.com/a-­‐z/federal-­‐bureau-­‐of-­‐narcotics/

5 Herer, Jack, Jeanie Cabarga, and Jeanie Herer. The Emperor Wears No Clothes: The Authoritative Historical Record of Cannabis and the Conspiracy Against Marijuana. N.p.: n.p., 1994. Print.

White 4

Here we have drug that is not like opium. Opium has all of the good of Dr. Jekyll and all the

evil of Mr. Hyde. This drug is entirely the monster Hyde, the harmful effect of which cannot

be measured. Some people will fly into a delirious rage, and they are temporarily

irresponsible and may commit violent crimes… It is dangerous to the mind and body.6

Additionally, Anslinger’s testimony included a letter from The Alamosa Daily Courier, which

said:

I wish I could show you what a small marihuana cigaret can do to one of our degenerate

Spanish-­‐speaking residents. That's why our problem is so great; the greatest percentage of

our population is composed of Spanish-­‐speaking persons, most of who are low mentally,

because of social and racial conditions.7

2.3 The Experiment: Marihuana Tax Act and Controlled Substance Act

I. Marihuana Tax Act of 1937

Due to the culmination of the anti-immigrant political environment and anti-

marijuana propaganda, Congress passed the Marihuana Tax Act of 1937, which imposed

a tax on the sale of cannabis, hemp and marijuana. This did not explicitly criminalize

marijuana possession, however it included penalties that could affect those in possession

of the drug marijuana with a potential of a $2000 fine or 5 years of imprisonment.8 After

this Act was introduced, marijuana was removed from pharmacies and in 1943

disappeared from the US Pharmacopeia.9

II. The Controlled Substance Act of 1970

6 Hearing on H.R. 6385, (April 1937), accessed at http://www.druglibrary.org/SCHAFFER/hemp/taxact/anslng1.htm

7 ADDITIONAL STATEMENT OF H. J. ANSLINGER, COMMISSIONER OF NARCOTICS http://www.druglibrary.org/schaffer/hemp/taxact/t10a.htm

8 Marijuana Tax Act Law & Legal Definition http://definitions.uslegal.com/m/marijuana-­‐tax-­‐act%20/

9 The Medical Cannabis Coalition of Hawaii http://mcchi.org/is-­‐it-­‐really-­‐medicine-­‐a-­‐not-­‐so-­‐brief-­‐but-­‐interesting-­‐history-­‐of-­‐medical-­‐marijuana/

White 5

The Controlled Substance Act (CSA) of 1970 categorized drugs into five

schedules based on the drugs’ accepted medical use and the potential for drug abuse and

dependency. Marijuana, a Schedule 1 drug, is defined by the CSA as not having

currently accepted medical uses and a high potential for abuse. Schedule I drugs, which

are the most dangerous drugs, also include Heroin, Lysergic Acid Diethylamide (LSD), 3,

4- Methylenedioxy-methamphetamine (Ecstasy), Methaqualone and Peyote.

2.4 A Response to a Failed Experiment: The Decriminalization of Marijuana

I. Decriminalization across the Nation

The decriminalization of small amounts of marijuana possession first began in the

United States with Oregon in 1973. During the rest of the 1970’s, Alaska, California,

Colorado, Nebraska, New York, North Carolina, Maine, Minnesota and Ohio joined

Oregon in decriminalizing marijuana. Decriminalization generally means that the

possession of reasonable amounts (as determined by the states) of cannabis is considered

a civil offense instead of a criminal offense. Laws in each state may vary.10 Nineteen

states as well as the District of Columbia have decriminalized marijuana.11

II. Decriminalized Marijuana in Nebraska

In 1979, Nebraska became one of the first states to decriminalize marijuana.12

The sale of any amount of cannabis results directly in a felony, which equates to 1-20

years in prison with a mandatory minimum of one year as well as a fine up to $20,000.

10 Which States Have Decriminalized Marijuana Possession? http://www.slate.com/articles/news_and_politics/explainer/2001/02/which_states_have_decriminalized_marijuana_possession.html

11 Alaska, California, Colorado, Connecticut, Delaware, District of Columbia, Maine, Maryland, Massachusetts, Minnesota, Mississippi, Missouri, Nebraska, Nevada, New York, North Carolina, Ohio, Oregon, Rhode Island, Vermont http://norml.org/aboutmarijuana/item/states-­‐that-­‐have-­‐decriminalized

12 Nebraska ranks high in marijuana-­‐related arrest rates, The Daily Nebraskan http://www.dailynebraskan.com/endowment/nebraska-­‐ranks-­‐high-­‐in-­‐marijuana-­‐related-­‐arrest-­‐rates/article_7b6b6a92-­‐e70d-­‐11e4-­‐9d68-­‐279676632c95.html

White 6

The penalties of possessing marijuana vary.13 For a chart illustrating Nebraska’s

decriminalization policy on the possession of cannabis, see Appendix, Section 8.2, Item

8.2A.

2.5 Comparing Different Levels of Legalization

There are three main levels of medical marijuana legalization. The most

expansive is referred to as Comprehensive Legalization of medical marijuana. After

Comprehensive, we have Limited Legalization, which would legalize the marijuana

derivative, Cannabinoid oil (CBD) for medical uses. The third level is the

Decriminalization of Marijuana. For a chart explaining these three levels of marijuana

legalization, see Appendix, Section 8.2, Item 8.2B.

3. The Economics of Choice

Medical marijuana has been legalized in some form in 40 out of 50 states not only

because there is proven medical benefits that are associated with the drug, but also

because patients are actively seeking out alternatives to mainstream prescription

medicines in order to treat their conditions. Understanding how patients could rationally

choose alternatives over federally-approved and quality-tested prescription medicine is

necessary for understanding the economics of choice.

Human beings care a lot about choice. In particular, we put a high level of

importance on having choice when it comes our health. For example, let say you have a

terminal illness. The doctor tells you that you have six to eight months left to live.

Having the ability to choose how to spend those last months of life would be extremely

valuable to you, especially if it means having some control over the quality of life you

achieve. You can choose to take a prescription medicine with known quality-of-life-

reducing side effects, or you can try a relatively new and unapproved alternative

medicine, which is said to have the same benefits as the prescription drug, but without the

side effects. To make the situation more complicated, you are also aware of some

13 Nebraska Marijuana Laws http://statelaws.findlaw.com/nebraska-­‐law/nebraska-­‐marijuana-­‐laws.html

White 7

research that suggests that alternative medicines, especially when mixed with prescription

drugs can pose dangerous health risks.14 What would you do?

Chances are, the potential to have a high quality of life during the last months of

your life would be worth the risk of using an alternative drug. It is to say for humans,

having autonomy over our destiny is so fundamentally valuable to us that often times we

put ourselves at risk, or willingly assume potential health dangers. Although it may seem

irrational to choose an unapproved alternative medicine over that which is federally

approved, if you take into consideration the great value we put on having choice, the

decision makes sense. Thus, patients assuming health risks to choose an alternative

medicine understands this choice and the alternative as more beneficial, or more valuable

than conventional medication alone.

4. The Impact of Marijuana as a Medical Alternative

I. Medical Marijuana Programs and Laws

In the United States, the idea of using marijuana as an alternative to synthetic

medicine was first put into state law in 1996 when California passed Proposition 215, or

the Compassionate Use Act, which was the first bill to allow access to medical marijuana

for patients suffering from certain diseases, as recommended by a physician.15 Although

this was the first state law that legalized medical cannabis, it was not the first time

marijuana was to be used as medicine. In fact, in 1976, the government began the

Compassionate Investigational New Drug program (IND), which allowed a limited

number of patients (15 in total) to receive marijuana approved by the government to treat

their ailments.16

14 Mixing drugs and herbal remedies may pose a major health risk, Global Mail http://www.theglobeandmail.com/life/health-­‐and-­‐fitness/health/mixing-­‐drugs-­‐and-­‐herbal-­‐remedies-­‐may-­‐pose-­‐a-­‐major-­‐health-­‐risk-­‐researchers-­‐warn/article4854590/

15 Proposition 215, California Department of Public Health https://www.cdph.ca.gov/programs/MMP/Pages/CompassionateUseact.aspx

16 Recipients of Legal Medical Cannabis, provided by the U.S. government under the Investigational New Drug Program (Compassionate Access I.N.D.) http://www.medicalcannabis.com/patients-­‐care-­‐givers/federal-­‐ind-­‐patients/

White 8

Since Proposition 215 in California, twenty-two more states and the District of

Columbia have followed suit to allow access to marijuana for medical purposes. In

addition, seventeen states have Limited Legalization of marijuana allowing access to low

THC, high CBD oil products and over twenty states have decriminalized the possession

of small reasonable amounts of marijuana. In total, 40 out of 50 states have some form of

marijuana legalization. Moreover, as of September 14, 2015, four states had pending

medical marijuana legislation tabled until 2016.17 For a map illustrating the medical

marijuana laws in the United States, see Appendix, Section 8.2, Item 8.2C.

II. Conditions Treatable with Medical Marijuana

Marijuana is cited as being able to help patients treat multiple life-altering

conditions, namely, Arthritis, Cancer, Crohn’s Disease, Epilepsy, HIV/AIDS and

Multiple Sclerosis (MS).18 For more information on these conditions, medical studies

and effects of medical marijuana, see Appendix, Section 8.1, Conditions Treatable

with Medical Marijuana. For a chart summarizing the previously mentioned conditions

as well as how medical marijuana helps, see Appendix, Section 8.2, Item 8.2D.

5. The Impact of Medical Marijuana Legalization on Society

Opponents of marijuana argue that legalizing the drug for medical use creates

many costs for society; often claiming that the costs far outweigh any benefit medical

marijuana may pose. The social costs alleged are that the legalization of medical

marijuana results in increased adolescent use, increased depression and suicide rates and

increases in violent crimes.

5.1 Adolescent Use

Since medical marijuana had been legalized in portions of the United States, the

relationship between state policy and adolescent use has been a controversial topic.

17 States with Pending Legislation http://medicalmarijuana.procon.org/view.resource.php?resourceID=002481

18 Illnesses Treatable with Medical Cannabis http://www.unitedpatientsgroup.com/resources/illnesses-­‐treatable

White 9

Many opponents cite that state policy in favor of medical marijuana sends the wrong

message to adolescents, causing them to view the drug as something accepted or allowed

for recreational use.19 This in effect causes adolescent use of the drug to increase

dramatically.

Despite these claims, many empirical studies have been completed that suggest

otherwise. A recent study published in the June of 2015 issue of the Lancet Psychiatry

Journal uses 24 years of data to examine the relationship between US medical marijuana

state laws and adolescent use in those states. After analyzing data from 1,098,270

adolescents, they suggest that although adolescent use seems to be high in states that

legalize medical marijuana, the passage of such laws does not increase adolescent use of

marijuana.20 Many others studies, such as that of E.K Choo et al., indicate that the

legalization of medical marijuana has little to no effect on adolescent use.21 A 2012 study

by Harper et Al. even suggests that the opposite may happen and adolescent use slightly

decreases as states legalize medical marijuana.22

5.2 Depression and Suicide

Many opponents of the legalization of medical marijuana believe that more use of

the drug leads to depression, which can eventually lead one to commit suicide. They

assert that consistent use of marijuana makes it harder for users to experience dopamine,

19 Marijuana legalization 'not sending a good message,' drug czar says, The Oregonian http://www.oregonlive.com/health/index.ssf/2013/01/white_house_drug_czar_stops_in_1.html

20 Deborah Hasin et al. “Medical marijuana laws and adolescent marijuana use in the USA from 1991 to 2014: results from annual, repeated cross-­‐sectional surveys” The Lancet Psychiatry. 2.7 (2015) 601-­‐608.

21 E.K Choo et al. “The Impact of State Medical Marijuana Legislation on Adolescent Marijuana Use.” Journal of Adolescent Health. 55 (2014) 160-­‐166.

22 Harper et al. “Do Medical Marijuana Laws Increase Marijuana Use? Replication Study and Extension.” The Official Journal of the American College of Epidemiology. 22.3 (2012) 207-­‐212

White 10

which can lead to the feeling of lethargy and apathy further leading to depression.23

Studies have been done that suggest that the use of marijuana may be associated with

depression, increased suicidal thoughts and suicide attempts.24 However, these claims

may be difficult to measure due to potential confounding factors such as personality.25

A study published in December 2014 that looks specifically at the association

between the legalization of medical marijuana and completed suicides. This study uses

state-level suicide data from the National Vital Statistics System’s Mortality Detail Files

from 1990-2007 and regression analysis to examine the relationship between the

legalization of medical marijuana and suicides per 100,000 people. After accounting for

economic circumstances, state laws and state-specific time trends, the study finds the

relationship between suicides and medical marijuana legalization not statistically

significant. Moreover, the study finds that legalization has a negative relationship with

the suicides of men between the ages of 20-29 and 30-39 years old with a reduction in

suicide rates by 10.8% and 9.4%, respectively. There also appears to be a negative but

less dramatic relationship with respect to women.26

5.3 Violent Crime and Property Crime

Another popular argument against legalizing marijuana for medical use is that

legalized marijuana in any form leads to more crime, and in particular higher violent

crime and property crime rates. They also argue that dispensaries and home cultivators

23 Smoking Cannabis DOES increase the risk of anxiety and depression, Daily Mail http://www.dailymail.co.uk/health/article-­‐2691837/Smoking-­‐cannabis-­‐DOES-­‐increase-­‐risk-­‐anxiety-­‐depression.html

24 Marijuana Myths and Facts, Office of National Drug Control Policy https://www.ncjrs.gov/ondcppubs/publications/pdf/marijuana_myths_facts.pdf

25 Van Ours J. et al. “Cannabis use and mental health problems.” Journal of Applied Econometrics. (2011) 26.7 1137-­‐1156.

26 Anderson et al. “Medical Marijuana Laws and Suicides by Gender and Age.” American Journal of Public Health. (2014) 104.12 2369-­‐2376

White 11

will become victims of robbery and burglary.27 This means that if medical marijuana and

dispensaries were legalized, the amount of violent crime and property crime in a specific

area would increase. However, contrary to this idea, studies have suggested that the

presence of medical marijuana might actually decrease violent crime and property crime

rates.28

A 2014 study published in the Journal PLoS ONE used FBI U.S. state panel data

to analyze the murder, rape, assault, robbery, burglary, larceny and auto theft rates in all

50 states between the years 1990 and 2006. During this 16-year span, 11 states legalized

medical marijuana: Alaska (1998), California (1996), Hawaii (2000), Maine (1999),

Montana (2004), Nevada (2000), Oregon (1998), Rhode Island (2006), Vermont (2004)

and Washington (1998). After analyzing the crime rates in each state before and after

legalizing medical marijuana, the research concludes that there is no increase in crime

rates resulting from medical marijuana legalization, and in fact, there is evidence that

suggest violent crimes such as homicide and assault may decrease.29

6. The Impact of Medical Marijuana Legalization on the Economy

Many opponents of marijuana suggest that such a large policy change would

result in more economic costs rather than benefits. In order to help examine this claim,

we investigate how the legalization of medical marijuana affects local job activity as well

as police department expenses. We examine the implications of this policy change on

banks and the liability they face if engaged in activities in violation of federal law as well

as how the inconsistency between state and federal law affects medical marijuana

dispensaries.

6.1 Job Creation 27 Crime is up in Colorado, Huffington Post http://www.huffingtonpost.com/kevin-­‐a-­‐sabet-­‐phd/crime-­‐is-­‐up-­‐in-­‐colorado-­‐w_b_5663046.html

28 Study: Marijuana Legalization Doesn’t Increase Crime, MSNBC http://www.msnbc.com/all/does-­‐marijuana-­‐lower-­‐the-­‐crime-­‐rate

29 Morris et al. “The Effect of Medical Marijuana Laws on Crime: Evidence from State Panel Data, 1990-­‐2006.” PLoS ONE (2014) 9.3

White 12

One is the benefits associated with legalized medical marijuana is legal job

creation. It is to say that many marijuana jobs already exist, however until the drug is

legalized in some form, the jobs remain in the black market.30 Throughout the United

States, it is estimated the medical marijuana industry has created close to 175,000 new

jobs.31 In Arizona alone, medical marijuana legalization is associated with an estimated

1,500 direct jobs for marijuana growers and dispensary employees as well as up to 5,000

indirect jobs in places like grocery stores.32 In Colorado, almost 10,000 direct jobs have

been created from the medical and recreational marijuana industries.33

6.2 Fewer Arrests and Cost Savings for Police Departments in MMS

Opponents of medical marijuana often cite that legalizing the drug associated with

higher law enforcement costs due to unseen consequences of legalization.34 However,

many studies suggest that legalizing medical marijuana is associated with lower costs in

law enforcement. According to 2010 American Civil Liberties Report, the United States

as a whole spends around $3.2 billion on enforcing marijuana enforcement laws and

Nebraska in particular is ranked number 13 among states and the District of Columbia in

spending per capita on enforcement for marijuana possession with a annual spending

30 Economic Benefits of Regulation, Halcyon Organics https://halcyonorganics.com/economic-­‐benefits-­‐of-­‐regulation/

31 Marijuana Jobs Higher Than Estimated, The Street http://www.thestreet.com/story/12659355/1/marijuana-­‐jobs-­‐higher-­‐than-­‐estimated.html

32 Study: Medical marijuana will create 1,500 jobs in Arizona, Cronkite News http://cronkitenewsonline.com/2013/04/study-­‐medical-­‐marijuana-­‐will-­‐create-­‐1500-­‐jobs-­‐in-­‐arizona/

33 Legal marijuana created thousands of jobs in Colorado, Vox http://www.vox.com/2014/5/20/5734394/legal-­‐marijuana-­‐created-­‐thousands-­‐of-­‐jobs-­‐in-­‐colorado

34 Alaska police chiefs say legalizing marijuana will increase funding, Alaska Dispatch News http://www.adn.com/article/20140618/alaska-­‐police-­‐chiefs-­‐say-­‐legalizing-­‐marijuana-­‐will-­‐increase-­‐funding-­‐training-­‐needs

White 13

equal to about $13 million.35 Moreover, during the year 2010, nearly 73% of all drug

arrests in Nebraska were for marijuana possession. It is also worth noting that according

to this 2010 report, Nebraska has the third highest arrest rate behind DC and New York at

417 arrests per 100,000 people as well as the highest black arrest rate at 1,699 black

arrests per 100,000 people.36 For a chart comparing Nebraska’s arrest rates with those of

D.C., New York, Maryland and Illinois, see Appendix, Section 8.2, Item 8.2E. Due to

the large amount of money spent on enforcing marijuana possession laws in Nebraska,

legalizing medical marijuana could result in a decrease in marijuana possession arrests

and decrease in enforcement costs.

6.3 Marijuana and Banks

One of the big questions associated with legalizing medical marijuana is the,

“Where do medical marijuana dispensaries deposit money?” Although medical

marijuana may be legalized in certain states, marijuana is still considered an illegal

Schedule I drug according to the Controlled Substance Act on the federal level. This

means, if a bank takes money from medical marijuana operations, it is engaged in

violation of federal law, classifying it as a money launderer. This could not only cause

large fines to be imposed upon the bank, but also substantial consequences could be

handed to bank employees, officers and directors. Depending on the amount of

marijuana involved, 5-20 years of prison may be involved.37 Fearing prosecution and

breaking federal law, banks have shut down marijuana-related accounts and refuse to

give loans to marijuana businesses.

6.4 Marijuana Dispensaries

35 Nebraska ranks high in marijuana-­‐related arrest rates, The Daily Nebraskan http://www.dailynebraskan.com/endowment/nebraska-­‐ranks-­‐high-­‐in-­‐marijuana-­‐related-­‐arrest-­‐rates/article_7b6b6a92-­‐e70d-­‐11e4-­‐9d68-­‐279676632c95.html

36 The War on Marijuana, American Civil Liberties Union https://www.aclu.org/files/assets/aclu-­‐thewaronmarijuana-­‐rel2.pdf

37 Marijuana Money Is Still A Pot Of Trouble For Banks, Forbes http://www.forbes.com/sites/jacobsullum/2014/09/18/local-­‐banks-­‐terrified-­‐by-­‐friendly-­‐neighborhood-­‐marijuana-­‐merchants/

White 14

Since the majority of financial institutions will not take money from medical

marijuana dispensaries because of the inconsistency in marijuana state and federal law,

dispensaries often operate cash-only businesses. This means their money has to be held

in safes. 38 Not only do these legal inconsistencies cause a cash-only business practice,

but they also result in more danger and higher costs for the dispensaries. A 2009 report

from the Denver Police Department estimated that almost 17% of marijuana retail shops

had been robbed or burglarized that year. Although this percentage is lower than that of

liquor stores (20%) or banks (34%), it is still a constant threat.39 As a result, dispensaries

are investing in armed security services to protect their multi-thousand dollar deposit

deliveries to various safes and to state offices to pay taxes.40 This legal inconsistency

does not only increase medical marijuana dispensary expenses, but also it effectively

hinders the legitimacy of a legal medical marijuana business.

7. Conclusion

In conclusion, states are legalizing medical marijuana for the potential benefits it

may hold for people suffering with conditions such as arthritis, cancer, Crohn’s Disease,

epilepsy, HIV/AIDS and multiple sclerosis. Opponents of this policy change believe that

the medical, societal and economic costs of legalizing medical marijuana far outweigh its

benefits. However, as shown through a plethora of studies, clinical trials and academic

papers, the costs of legalizing medical marijuana may be effectively overstated in our

society. Much of the research suggests that marijuana’s benefits may in fact hold more

medical, societal and economic benefits than what has been commonly acknowledged.

38 Banking for Pot Industry Hits a Roadblock, NY Times http://www.nytimes.com/2015/07/31/business/dealbook/federal-­‐reserve-­‐denies-­‐credit-­‐union-­‐for-­‐cannabis.html

39 Robber Gangs Terrorize Colorado Pot Shops, NBC News http://www.nbcnews.com/storyline/legal-­‐pot/high-­‐crimes-­‐robber-­‐gangs-­‐terrorize-­‐colorado-­‐pot-­‐shops-­‐n20111

40 The First Bank of Bud, NY Times http://www.nytimes.com/2015/02/08/business/marijuana-­‐industry-­‐in-­‐colorado-­‐eager-­‐for-­‐its-­‐own-­‐bank-­‐waits-­‐on-­‐the-­‐fed.html?_r=0

White 15

Moreover, understanding the historical anomaly of the drug’s illegality will help

one be better informed of the implications of the drug’s current Schedule I status in the

United States. Marijuana is not a new medicine in the United States as the drug was once

commonly sold in pharmacies across the nation during the ninetieth century. Although it

was once publically used and sold, the criminalization of marijuana was a failed

experiment based on the culmination anti-immigrant fear mongering and the association

of immigrants and racial minorities with marijuana. This failed experiment to rid society

of the artificially created ills caused by that association was not without consequences.

As a result of this experiment, countless Americans and Nebraskans have been

unable to access marijuana for medical purposes. Despite this, throughout the last few

decades, marijuana has begun to make its way back into society for such purposes. It

began with state decriminalization of the drug during the 1970’s. Around this same time,

in 1976, the government started the Compassionate Investigational New Drug program

(IND), which allowed a limited number of patients to receive marijuana to treat their

medical conditions. Later, in 1996, California passed Proposition 215, or Compassionate

Use Act, which was the first state bill to allow statewide medical marijuana use. Since

Proposition 215, 22 more states and D.C. have passed similar legislation. In addition, 17

states that have passed limited legalization laws. The evidence on medical marijuana is

clear. 40 out of 50 states have taken an activist role on medical marijuana, and as a

result, their residents have experienced numerous medical benefits. At this time,

Nebraska must make a decision on its medical marijuana policy; no decision does have

consequences.

White 16

8. Appendix

8.1 Conditions Treatable with Medical Marijuana

Marijuana is cited as being able to help patients treat multiple life-altering

conditions, namely, Arthritis, Cancer, Crohn’s Disease, Epilepsy, HIV/AIDS and

Multiple Sclerosis (MS).41 This information is continued from Section 4, Conditions

Treatable with Medical Marijuana.

I. Arthritis

Over 336,000 Nebraskans are affected by Arthritis according to the Arthritis

Foundation of Nebraska.42 This means over 17% of Nebraska residents are affected by

this condition. Arthritis refers to over 100 different types of joint pain and diseases that

cause moderate to severe pain, swelling and stiffness.43 Two common types of arthritis

are rheumatoid arthritis and osteoarthritis.44

A 2014 study published in the Journal of Rheumatology examined the

relationship between cannabinoids, and specifically two cannabinoid receptors (CB1 and

CB2) and rheumatoid arthritis. The study concludes that marijuana may be able to fight

inflammation of the joints by activating the CB2 receptor pathways. These pathways

were found to be high within the joint tissue of arthritis patients.45

II. Cancer

41 Illnesses Treatable with Medical Cannabis http://www.unitedpatientsgroup.com/resources/illnesses-­‐treatable

42 Nebraskans Affected by Arthritis, Nebraska Arthritis Foundation http://www.arthritis.org/nebraska/

43 What Is Arthritis?, Nebraska Arthritis Foundation http://www.arthritis.org/about-­‐arthritis/understanding-­‐arthritis/what-­‐is-­‐arthritis.php

44 Arthritis and Medical Marijuana, Americans for Safe Access http://www.safeaccessnow.org/arthritis_booklet#arthritis

45 Huan Gui et al. “Expression of cannabinoid receptor 2 and its inhibitory effects on synovial fibroblasts in rheumatoid arthritis.” Journal of Rheumatology 53 (2014): doi:10.1093/rheumatology/ket447

White 17

According to 2012 data from Center for Disease Control and Prevention (CDC),

8,953 Nebraska residents were living with cancer.46 Today, one of the most common

ways to treat cancer is with chemotherapy, which includes the use of a number of strong

drugs to kill the cancer cells.47 Unfortunately, chemotherapy comes with a number of

side effects such as Nausea, vomiting, appetite loss, hair loss and bone marrow change,

which can lead to uneasiness and pain for cancer patients.

Medical marijuana is believed to help alleviate the side effects that come with

chemotherapy. A 2015 study published in the Clinical Pharmacology and Therapeutics

Journal finds that marijuana can help cure the nausea and vomiting associated with

chemotherapy treatment. In a systematic review including 1,366 patients, cannabinoids

were found to be much more effective than other antiemetic medications, meaning

cannabinoids were better are treating nausea and vomiting related to chemotherapy.

According to this review, the NNT, or number needed to treat one person was six to treat

nausea and eight to control vomiting.48 After analyzing 23 randomized clinical trials that

compared cannabinoids with placebo and other antiemetic drugs, another 2015 study

concluded, “Cannabis-based medications may be useful for treating refractory

chemotherapy-induced nausea and vomiting.49”

III. Crohn’s Disease

46 Cancer Incidence Counts by U.S. Census Region and Division, State and Metro Area. https://nccd.cdc.gov/USCS/cancersbystateandregion.aspx?Year=2012&Variable1=Nebraska

47 Chemotherapy, American Cancer Society http://www.cancer.org/treatment/treatmentsandsideeffects/treatmenttypes/chemotherapy/index

48 Abrams and Guzman. “Cannabis in Cancer Care.” Clinical Pharmacology and Therapeutics (2015) 97.6 575-­‐586

49 Smith, Azariah, Lavender, Stoner, Bettiol. “Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy.” Cochrane Database of Systematic Reviews. (2015) 11. DOI: 10.1002/14651858.CD009464.pub2.

White 18

Approximately 780,000 Americans live with Crohn’s Disease, one of the most

common inflammatory bowel diseases (IBDs) in the United States.50 Symptoms

associated with this disease include the inflammation of the gastrointestinal tract (GI

tract), chronic abdominal pain and even loss of appetite.51

Studies show medical marijuana can help alleviate the symptoms associated with

Crohn’s Disease and IBDs. A 2012 observation study by Lahat A et al. finds that IBD

patients using marijuana experienced a higher quality of life and weight gain.52 A 2013

survey study of 292 IBD patients completed by Ravikoff Allegretti et al. finds around

16% patients in the US have used cannabis to self-medicate symptoms such as abdominal

pain, appetite loss and nausea. The majority of these patients indicate that marijuana

helps alleviate pain and nausea.53

A 2013 clinical trial finds that patients who used THC-rich cannabis received

significant clinical benefits without side effects. 21 patients who did not respond to

traditional therapy were chosen for the clinical trial and were randomly assigned to a

group. Over the course of eight weeks, eleven patients received cannabis in the form of

cigarettes and ten received placebo. The study group was noted as having “significantly

less pain, improved appetite and a higher satisfaction from the treatment.” In addition, a

clinical response was observed in 10 of 11 cannabis group subjects and 5 of 11 of those

subjects achieved complete remission.54

50 Inflammatory Bowel Disease, Crohn's & Colitis Foundation of America http://www.ccfa.org/assets/pdfs/updatedibdfactbook.pdf

51 What is Crohn’s Disease?, Crohn's & Colitis Foundation of America http://www.ccfa.org/what-­‐are-­‐crohns-­‐and-­‐colitis/what-­‐is-­‐crohns-­‐disease/

52 Lahat A et al. “Impact of cannabis treatment on the quality of life, weight and clinical disease activity in inflammatory bowel disease patients: a pilot prospective study.” Digestion. (2012) 85 1-­‐8

53 Ravikoff Allegretti et al. “Marijuana Use Patterns Among Patients with Inflammatory Bowel Disease” Inflamm Bowel Dis. (2013) 19.13 2809-­‐2814.

54 Naftali et al. “Cannabis Induces a Clinical Response in Patients With Crohn’s Disease: A Prospective Placebo-­‐Controlled Study” Clinical Gastroenterology and Hepatology (2013) 11 1276-­‐1280.

White 19

IV. Epilepsy

Epilepsy, a neurological disorder, affects millions of Americans,55 and in

Nebraska, Epilepsy affects an estimated 25,000 residents.56 This condition causes

uncontrollable seizures or periods of unusual behavior, which can lead to loss of

consciousness.57 Epilepsy can be very traumatic and potentially dangerous for persons

and families affected by the disease, however many believe that marijuana may help

reduce the amount of seizures patients experience.

A 2004 study surveyed 136 epilepsy patients and found that 28 reported cannabis

use. The majority of these patients noted a drop in seizure occurrence and severity.58 A

2013 survey study of 19 severely epileptic children found that after receiving cannabis

extracts, two of the children became seizure free and 8 experienced a reduction in

frequency by 80%.59 A 2015 survey study of 75 parents with epileptic children in

Colorado found that one third of the children experienced more than a 50% reduction in

seizure occurrence after being treated with an oral cannabis extract.60 There have also

been a number of clinical trials, case series and case reports on cannabinoids and the

treatment of epilepsy. The current clinical evidence has been summarized by Friedman

and Devinsky. Many reports show significant improvements while some show little to no

55 Epilepsy Statistics, Epilepsy Foundation http://www.epilepsy.com/learn/epilepsy-­‐statistics

56 Nebraskans Affected by Epilepsy, Nebraska Walk For Epilepsy http://www.nebraskaepilepsywalk.com/faf/home/default.asp?ievent=1134471

57 Overview of Epilepsy, Mayo Clinic http://www.mayoclinic.org/diseases-­‐conditions/epilepsy/home/ovc-­‐20117206

58 Gross et al. “Marijuana use and epilepsy: prevalence in patients of a tertiary care epilepsy center.” Neurology .2004 62 2095-­‐2097

59 Porter and Jacobson. “Report of a parent survey of cannabidiol-­‐enriched cannabis use in pediatric treatment-­‐resistant epilepsy.” Epilepsy Behav. (2013) 29 574-­‐577

60 Press et al. “Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy.” Epilepsy Behav (2015) 45 49-­‐52.

White 20

improvement.61 In addition, data for a new clinical trial is currently being collected at

Denver Health Medical Center. Results should be available February 2016.62

V. HIV and AIDS

According to the HIV and AIDS Surveillance Program Summary Report by the

Department of Health and Human Services, there were 2,431 persons living with

HIV/AIDS in Nebraska.63 Side effects often associated with the treatment of HIV/AIDS

include: diarrhea, headaches, nausea, vomiting, nerve pain and appetite loss.64 These side

effects can lead to severe discomfort and pain for patients.

Studies have shown that medical marijuana helps patients undergoing HIV/AIDS

treatment and the symptoms associated with it. A 2005 cross-sectional anonymous

questionnaire study found out of 523 responses, almost one-third (27%, 143/523) of the

HIV patients reported using marijuana to treat their condition. 97% of patients noted an

improved appetite, 94% experienced improved muscle pain and 93% felt that their nausea

and anxiety improved.65 A 2007 double-blind placebo-controlled study finds that

compared with placebo, marijuana and marijuana derived dronabinol helped increase

daily caloric intake and body weight in HIV-positive patients. Marijuana was also

credited for improved ratings of sleep.66

61 Friedman and Devinsky. “Cannabinoids in the Treatment of Epilepsy.” The New England Journal of Medicine. (2015) 373 1048-­‐1058

62 Genetic Analysis Between Charlotte's Web Responders Versus Non-­‐ Responders in a Dravet Population https://clinicaltrials.gov/ct2/show/results/NCT02229032?term=Dravet&rank=1

63HIV and AIDS Report, Department of Health & Human Services of Nebraska http://dhhs.ne.gov/publichealth/Documents/HIVSurveillanceProgramSummaryReportThrough2014.pdf

64 HIV/AIDS Drug Side Effects, WebMD http://www.webmd.com/hiv-­‐aids/aids-­‐hiv-­‐medication-­‐side-­‐effects

65 Woolridge et al. “Cannabis Use in HIV for Pain and Other Medical Symptoms.” Journal of Pain and Symptom Management (2005) 29.4 358-­‐367

66 Haney et al. “Dronabinol and Marijuana in HIV-­‐Positive Marijuana Smokers.” J Acquir Immune Defic Syndr” (2007) 45.5 545-­‐554

White 21

VI. Multiple Sclerosis

According to the University of Nebraska Medical Center, an estimated 1,600 to

1,800 Nebraska residents are currently living with Multiple Sclerosis (MS).67 MS is an

unpredictable and degenerative disease that attacks the central nervous system and is

often debilitating. It causes an array of symptoms that can include inflammation,

muscular weakness, chronic pain, depression and spasticity.68 This disease typically

shows up in people between the ages of 20 and 50, but can also occur in young children

and older adults.69

A 2006 placebo-controlled study found that MS patients who use cannabinoid extracts

experienced relief from pain, spasticity and bladder-related problems.70 A 2011 double

blind placebo-based study found that MS patients using an oral spray derived from

cannabis had a significant improvement in spasticity.71 A 2012 double blind placebo-

based study found that after twelve weeks of treatment with an oral based cannabis

extract. MS patients experienced a rate of relief from muscle stiffness almost twice as

high as compared to those who were on the placebo. The patients also cited relief in

body pain, spasms and sleep quality.72 A 2013 randomized placebo-controlled clinical

trial at the University of California at San Diego concluded, “Smoked cannabis was

67 Number of cases in Nebraska, University of Nebraska Medical Center http://www.unmc.edu/news.cfm?match=754

68 MS Symptoms, National MS Society http://www.nationalmssociety.org/Symptoms-­‐Diagnosis/MS-­‐Symptoms

69 What is MS?, National MS Society http://www.nationalmssociety.org/What-­‐is-­‐MS/Who-­‐Gets-­‐MS

70 Wade et al. “Long-­‐term use of cannabis-­‐based medicine in the treatment of spasticity and other symptoms in multiple sclerosis.” Multiple Sclerosis (2006) 12 639-­‐645

71 Novotna, et al. “A randomized, double-­‐blind, placebo-­‐controlled, parallel-­‐group, enriched-­‐design study of nabiximols (Sativex®), as add-­‐on therapy, in subjects with refractory spasticity caused by multiple sclerosis.” European Journal of Neurology (2011) 18 1122–1131.

72 Zajicek et al. “Multiple Sclerosis and Extract of Cannabis: Results of MUSEC trial” J Neurol Neurosurg Psychiatry (2012) 83 1125-­‐1132.

White 22

superior to placebo in symptom and pain reduction in participants with treatment-

resistant spasticity.73”

8.2 Charts, Graphs and Other Visual Representations

Item 8.2A illustrates Nebraska’s decriminalization policy on the possession of cannabis.

Marijuana Possession in Nebraska

Possession Penalty Incarceration Maximum Fine

Under 1 oz.

(1st Offense)

Citation None Up to $300

Under 1 oz.

(2nd Offense)

Citation Up to 5 days in jail, Class

IV misdemeanor

$400

Under 1 oz.

(3rd Offense)

Class IIIA

misdemeanor

Up to 7 days in jail $500

Over 1 oz. Class IIIA

misdemeanor

3 months Up to $500

Over 1 lb. Class IV felony 5 years Up to $10,000

73 Corey-­‐Bloom et al. “Smoked Cannabis for Spasticity in Multiple Sclerosis: A Randomized, Placebo-­‐Controlled Trial.” CMAJ : Canadian Medical Association Journal 184.10 (2012): 1143–1150

White 23

Item 8.2B is a chart detailing the three levels of marijuana legalization as described by

the National Conference of State Legislators.

Type of Legalization What does this

mean? Participating States

Comprehensive Legalization of

Medical Marijuana

1. Protection from criminal penalties for using marijuana for a medical purpose;

2. Access to marijuana through home cultivation, dispensaries or some other system that is likely to be implemented;

3. It allows a variety of strains, including those more than "low THC;" and

4. It allows either smoking or vaporization of some kind of marijuana products, plant material or extract.

23 States and D.C. 1. Alaska (1998) 2. Arizona (2010) 3. California (1996) 4. Colorado (2000) 5. Connecticut (2012) 6. D.C. (2010) 7. Delaware (2011) 8. Hawaii (2000) 9. Illinois (2013) 10. Maine (1999) 11. Maryland (2014) 12. Massachusetts (2012) 13. Michigan (2008) 14. Minnesota (2014) 15. Montana (2004) 16. Nevada (2000) 17. New Hampshire (2013) 18. New Jersey (2010) 19. New Mexico (2007) 20. New York (2014) 21. Oregon (1998) 22. Rhode Island (2006) 23. Vermont (2004) 24. Washington (1998)

Limited Legalization­ Low THC/high CBD­

Cannabidiol

Allows persons suffering from certain conditions to use “low THC, high cannabidiol” products for medicinal reasons or as a legal defense

17 states (including Louisiana, not shown in map) have approved use of "low THC, high cannabidiol (CBD)" products for medical reasons in limited situations or as a legal defense.

Decriminalization of Marijuana

This generally means certain small, personal­consumption amounts are a civil or local infraction, not a state crime (or are a lowest misdemeanor with no possibility of jail time).

Twenty states and the District of Columbia have decriminalized small amounts marijuana. Nebraska is one of these states.

Source: National Conference of State Legislators

White 24

Item 8.2C is a map illustrating the medical marijuana laws in the United States. The

green states have comprehensive medical marijuana laws, the light blue states have

limited CBD legalization and the states filled with red diagonal lines are those with

pending medical marijuana legislation as of September 14, 2015.

White 25

Item 8.2D is a chart summarizing conditions treatable with medical marijuana and

Nebraskans affected.

Conditions What is it? Nebraskans Affected Symptoms/Side Effects

Treated

Arthritis Refers to over 100 different joint

pain diseases, Ex: rheumatoid and

osteoarthritis

Over 336,000 residents, or

over 17% of Nebraskans

Severe pain, stiffness,

inflammation

Cancer Many types of cancer, typically

treated with Chemotherapy

8,953 Nebraskans affected Chemo side effects: nausea,

vomiting, appetite loss, pain

Crohn’s Disease One of the most common

inflammatory bowel diseases (IBDs)

Appx. 780,000 Americans

(don’t have NE data)

Inflammation of GI tract,

abdominal pain, appetite loss

Epilepsy Neurological disorder that cause

uncontrollable seizures

Appx. 25,000 residents Seizures

HIV/AIDS A degenerative disease 2,431 persons in Nebraska Headaches, nausea, vomiting,

nerve pain, appetite loss

Multiple Sclerosis (MS) A disease that attacks central

nervous system, often debilitating

1,600-1,800 Nebraskans

residents affected

Inflammation, chronic pain,

depression, muscle spasticity

White 26

Item 8.2E is a chart that shows the top 5 states by marijuana possession arrest rate.

Nebraska is listed as number three with a rate of 417 per 100,000 people. It also

demonstrates the marijuana possession rate for black people. Nebraska is listed as

number one with an arrest rate of 1,677 per 100,000 people.

1489

1192

1699

790

1526

0

200

400

600

800

1000

1200

1400

1600

1800

D.C. New York Nebraska Maryland Illinois

Top 5 States by Marijuana Possesion Arrest Rate (also shown Black Arrest Rate)

Arrest Rate (per 100,000 people)

Black Arrest Rate (per 100,00 people)

Source: June 2013 ACLU Report